Rebiotix trumpets positive — but preliminary — results for microbiome drug

Rebiotix trumpets positive — but preliminary — results for microbiome drug

STAT Plus: Rebiotix unveils positive — but preliminary — data on its microbiome drug for C. diff infections

By KATE SHERIDAN

DAVID GOULDING/WELLCOME TRUST SANGER INSTITUTE

Rebiotix announced Wednesday that its donor stool-based therapeutic for deadly Clostridium difficile infections was successful.

READ MORE